Combining Fat-to-Muscle Ratio and Alanine Aminotransferase/Aspartate Aminotransferase Ratio in the Prediction of Cardiometabolic Risk: A Cross-Sectional Study

References

• Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1736–1788.
   PubMed Web of Science ®Google Scholar
• Kyu HH, Abate D, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2018;392(10159):1859–1922.
   PubMed Web of Science ®Google Scholar
• Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010;56(14):1113–1132. doi:10.1016/j.jacc.2010.05.034
   PubMed Web of Science ®Google Scholar
• Guembe MJ, Fernandez-Lazaro CI, Sayon-Orea C, Toledo E, Moreno-Iribas C, Investigators RS. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort. Cardiovasc Diabetol. 2020;19(1):195. doi:10.1186/s12933-020-01166-6
   PubMed Web of Science ®Google Scholar
• Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT. Visceral and intrahepatic fat are associated with cardiometabolic risk factors above other ectopic fat depots: the Framingham heart study. Am J Med. 2018;131(6):684–692 e612. doi:10.1016/j.amjmed.2018.02.002
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JB, Kang J, et al. Association between sarcopenia level and metabolic syndrome. PLoS One. 2021;16(3):e0248856. doi:10.1371/journal.pone.0248856
   PubMed Web of Science ®Google Scholar
• Muzurović E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770. doi:10.1016/j.metabol.2021.154770
   PubMed Web of Science ®Google Scholar
• Khadra D, Itani L, Tannir H, Kreidieh D, El Masri D, El Ghoch M. Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: a systematic review and meta-analysis. World J Diabetes. 2019;10(5):311–323. doi:10.4239/wjd.v10.i5.311
   PubMed Web of Science ®Google Scholar
• Liu D, Zhong J, Ruan Y, Zhang Z, Sun J, Chen H. The association between fat-to-muscle ratio and metabolic disorders in type 2 diabetes. Diabetol Metab Syndr. 2021;13(1):129. doi:10.1186/s13098-021-00748-y
   PubMed Web of Science ®Google Scholar
• Seo YG, Song HJ, Song YR. Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults. J Cachexia Sarcopenia Muscle. 2020;11(3):710–725. doi:10.1002/jcsm.12548
   PubMed Web of Science ®Google Scholar
• Marchesini G, Brizi M, Bianchi G, et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes. 2001;50(8):1844–1850. doi:10.2337/diabetes.50.8.1844
   PubMed Web of Science ®Google Scholar
• Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51(6):1889–1895. doi:10.2337/diabetes.51.6.1889
   PubMed Web of Science ®Google Scholar
• Liu C, Shao M, Lu L, Zhao C, Qiu L, Liu Z. Obesity, insulin resistance and their interaction on liver enzymes. PLoS One. 2021;16(4):e0249299. doi:10.1371/journal.pone.0249299
   PubMed Web of Science ®Google Scholar
• Gómez-Sámano MA, Cuevas-Ramos D, Mehta R, Brau-Figueroa H, Meza-Arana CE, Gulias-Herrero A. Association of alanine aminotransferase levels (ALT) with the Hepatic insulin resistance index (HIRI): a cross-sectional study. BMC Endocr Disord. 2012;12:16. doi:10.1186/1472-6823-12-16
   PubMed Web of Science ®Google Scholar
• Kawamoto R, Kohara K, Kusunoki T, Tabara Y, Abe M, Miki T. Alanine aminotransferase/aspartate aminotransferase ratio is the best surrogate marker for insulin resistance in non-obese Japanese adults. Cardiovasc Diabetol. 2012;11:117. doi:10.1186/1475-2840-11-117
   PubMed Web of Science ®Google Scholar
• Zhao L, Cheng J, Chen Y, et al. Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population. Nutr Metab. 2017;14:64. doi:10.1186/s12986-017-0219-x
   Google Scholar
• Lopez-Lopez JP, Cohen DD, Ney-Salazar D, et al. The prediction of metabolic syndrome alterations is improved by combining waist circumference and handgrip strength measurements compared to either alone. Cardiovasc Diabetol. 2021;20(1):68. doi:10.1186/s12933-021-01256-z
   PubMed Web of Science ®Google Scholar
• Kim SR, Lerman LO. Diagnostic imaging in the management of patients with metabolic syndrome. Transl Res. 2018;194:1–18. doi:10.1016/j.trsl.2017.10.009
   PubMed Web of Science ®Google Scholar
• Kim G, Lee SE, Jun JE, et al. Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study. Cardiovasc Diabetol. 2018;17(1):23. doi:10.1186/s12933-018-0659-2
   PubMedGoogle Scholar
• Coelho C, Bragança M, de Oliveira BR, et al. Incidence of metabolic syndrome in adults with healthy weight, normal weight obesity, and overweight/obesity. Nutrition. 2021;85:111134. doi:10.1016/j.nut.2020.111134
   PubMed Web of Science ®Google Scholar
• Chung JY, Kang HT, Lee DC, Lee HR, Lee YJ. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity. Arch Gerontol Geriatr. 2013;56(1):270–278. doi:10.1016/j.archger.2012.09.007
   PubMed Web of Science ®Google Scholar
• Xu K, Zhu HJ, Chen S, et al. Fat-to-muscle ratio: a new anthropometric indicator for predicting metabolic syndrome in the Han and Bouyei Populations from Guizhou Province, China. Biomed Environ Sci. 2018;31(4):261–271. doi:10.3967/bes2018.034
   PubMed Web of Science ®Google Scholar
• Ramirez-Velez R, Carrillo HA, Correa-Bautista JE, et al. Fat-to-muscle ratio: a new anthropometric indicator as a screening tool for metabolic syndrome in young Colombian people. Nutrients. 2018;10(8):1027. doi:10.3390/nu10081027
   PubMed Web of Science ®Google Scholar
• Baek SJ, Nam GE, Han KD, et al. Sarcopenia and sarcopenic obesity and their association with dyslipidemia in Korean elderly men: the 2008–2010 Korea national health and nutrition examination survey. J Endocrinol Invest. 2014;37(3):247–260. doi:10.1007/s40618-013-0011-3
   PubMed Web of Science ®Google Scholar
• Chen YY, Fang WH, Wang CC, et al. Fat-to-muscle ratio is a useful index for cardiometabolic risks: a population-based observational study. PLoS One. 2019;14(4):e0214994. doi:10.1371/journal.pone.0214994
   PubMed Web of Science ®Google Scholar
• Gamboa-Gomez CI, Simental-Mendia LE, Rodriguez-Moran M, Guerrero-Romero F. The fat-to-lean mass ratio, a novel anthropometric index, is associated to glucose metabolic disorders. Eur J Intern Med. 2019;63:74–78. doi:10.1016/j.ejim.2019.03.017
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Magkos F, Mohammed BS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proce Nat Acad Sci. 2009;106(36):15430–15435. doi:10.1073/pnas.0904944106
   PubMed Web of Science ®Google Scholar
• Rotman Y, Neuschwander-Tetri BA. Liver fat accumulation as a barometer of insulin responsiveness again points to adipose tissue as the culprit. Hepatology. 2017;65(4):1088–1090. doi:10.1002/hep.29094
   PubMed Web of Science ®Google Scholar
• Magkos F, Fabbrini E, Mohammed BS, Patterson BW, Klein S. Increased whole-body adiposity without a concomitant increase in liver fat is not associated with augmented metabolic dysfunction. Obesity. 2010;18(8):1510–1515. doi:10.1038/oby.2010.90
   PubMed Web of Science ®Google Scholar
• Zou Y, Zhong L, Hu C, Sheng G. Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study. Lipids Health Dis. 2020;19(1):245. doi:10.1186/s12944-020-01419-z
   PubMed Web of Science ®Google Scholar
• Kohsari M, Moradinazar M, Rahimi Z, Pasdar Y, Shakiba E. Liver enzymes and their association with some cardiometabolic diseases: evidence from a large kurdish cohort. Biomed Res Int. 2021;2021:5584452. doi:10.1155/2021/5584452
   PubMed Web of Science ®Google Scholar
• Lee K, Yang JH. Which liver enzymes are better indicators of metabolic syndrome in adolescents: the Fifth Korea national health and nutrition examination survey, 2010. Metab Syndr Relat Disord. 2013;11(4):229–235. doi:10.1089/met.2012.0153
   PubMed Web of Science ®Google Scholar
• Chen L, Zhang K, Li X, et al. Association between aspartate aminotransferase to alanine aminotransferase ratio and incidence of type 2 diabetes mellitus in the Japanese population: a secondary analysis of a retrospective cohort study. Diabetes Metab Syndr Obes. 2021;14:4483–4495. doi:10.2147/DMSO.S337416
   PubMed Web of Science ®Google Scholar
• Sinha R, Dufour S, Petersen KF, et al. Assessment of skeletal muscle triglyceride content by (1)H nuclear magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes. 2002;51(4):1022–1027. doi:10.2337/diabetes.51.4.1022
   PubMed Web of Science ®Google Scholar
• Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87(7):3023–3028. doi:10.1210/jcem.87.7.8638
   PubMed Web of Science ®Google Scholar
• Rana MN, Neeland IJ. Adipose tissue inflammation and cardiovascular disease: an update. Curr Diab Rep. 2022;22(1):27–37. doi:10.1007/s11892-021-01446-9
   PubMed Web of Science ®Google Scholar
• Tanaka M, Okada H, Hashimoto Y, et al. Relationship between metabolic syndrome and trunk muscle quality as well as quantity evaluated by computed tomography. Clin Nutr. 2020;39(6):1818–1825. doi:10.1016/j.clnu.2019.07.021
   PubMed Web of Science ®Google Scholar
• Wu H, Liu M, Chi VTQ, et al. Handgrip strength is inversely associated with metabolic syndrome and its separate components in middle aged and older adults: a large-scale population-based study. Metabolism. 2019;93:61–67. doi:10.1016/j.metabol.2019.01.011
   PubMed Web of Science ®Google Scholar
• Francque S. The liver and the cardiovascular system: two of a kind? J Am Heart Assoc. 2021;10(8):e020286. doi:10.1161/JAHA.121.020286
   PubMed Web of Science ®Google Scholar